These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. US policy may encourage counterfeit drugs. Bouchie A Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826 [No Abstract] [Full Text] [Related]
8. Patent fight sparks biological warfare in the drug industry. Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662 [No Abstract] [Full Text] [Related]
9. Protecting rights to early-stage technology. Shuster MJ; Su H; Blaug S Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151 [No Abstract] [Full Text] [Related]
10. Owning the secret of life: biotechnology and property rights revisited. Yelpaala K McGeorge Law Rev; 2000; 32(1):111-219. PubMed ID: 15709267 [No Abstract] [Full Text] [Related]
11. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape. Lu DL; Kowalski TJ; Jarecki-Black J Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040 [No Abstract] [Full Text] [Related]
12. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech. Garber K Science; 2006 May; 312(5775):827. PubMed ID: 16690824 [No Abstract] [Full Text] [Related]
19. Pharmaceutical patent life-cycle management after KSR v. Teleflex. Furrow ME Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462 [No Abstract] [Full Text] [Related]
20. Patent watch: Progress in three key patent disputes in 2009. Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395 [No Abstract] [Full Text] [Related] [Next] [New Search]